Coagulation abnormalities and thrombosis in patients with COVID-19
By M. Levi, J. Thachil, T. Iba, J. Levy. The Lancet Haematology, 2020
1,332 citations recorded by the source corpus.
Subfields: Infectious Diseases, Internal Medicine, Oncology
View Paper: https://www.semanticscholar.org/paper/cc0f5685efe52e55411785d463c8c47e4725c437
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Coronavirus (COVID-19) (2020, background): “venous or arterial thromboembolic event(s) [76, 77], compared with 10–25% of hospitalized patients [77, 78].”
- Predictors of COVID-19 severity: A literature review (2020, background): “If this is proven, then targeting ACE2 expression in the nasal epithelium may be a potential therapeutic approach to reduce transmission of COVID-19.”